<DOC>
	<DOCNO>NCT01753973</DOCNO>
	<brief_summary>Metabolic syndrome ( MS ) characterize series metabolic hemodynamic parameter hypertension ( hypertension ) , abdominal obesity , dyslipidemia , abnormal glucose metabolism insulin resistance , result increase cardiovascular morbidity mortality risk develop type 2 diabetes mellitus ( T2DM ) . Metabolic syndrome common event renal transplantation . The prevalence MS increase post-transplant weight gain . In renal transplant recipient , SM associate CVD , diabetes transplantation , worsen renal function graft loss . Immunosuppressant medication primary effect pathophysiology MS. Several study evaluate prevalence impact metabolic syndrome renal transplant recipient obesity , hypertension , dyslipidemia use immunosuppressant . The objective study determine whether determination metabolic syndrome 6 month predict condition 12 month , determine prevalence metabolic syndrome 12 month , assess prevalence obesity overweight population ass prevalence diabetes mellitus renal transplantation . Patients meet inclusion criterion meet exclusion criterion invite participate study , sign Instrument Consent ( IC ) inform objective procedure study perform , age 18 60 year , sex , renal transplant recipient Renal Transplant Unit , Hospital das Clinicas , FMUSP live donor decease use immunosuppressive regimen consist tacrolimus , mycophenolate sodium prednisone . Sampling conducted laboratory test , fill questionnaire quality life anthropometric measure .</brief_summary>
	<brief_title>Assessing Prevalence Metabolic Syndrome Renal Transplantation</brief_title>
	<detailed_description>Metabolic syndrome ( MS ) characterize presence number metabolic hemodynamic disorder hypertension ( HBP ) , abdominal obesity , dyslipidemia , abnormal glucose metabolism insulin resistance , result increase cardiovascular morbidity mortality risk develop type 2 diabetes mellitus . The concept metabolic syndrome ( MS ) first describe Reaven 1988 combination obesity , dyslipidemia , hypertension fast hyperglycemia , insulin resistance inflammation common pathophysiological disorder cardiovascular disease ( CVD ) . But first comprehensive definition MS establish 1998 , World Health Organization ( WHO ) , order facilitate research area point key indicator SM presence hyperglycemia / resistance insulin associate day metabolic abnormality ( hypertension , dyslipidemia , obesity , microalbuminuria ) . In general population , presence MS associate increase risk develop diabetes mellitus ( DM ) cardiovascular disease . Some study associate SM appearance proteinuria reduction value glomerular filtration rate ( GFR ) , suggest association SM chronic kidney disease ( CKD ) . Metabolic syndrome ( MS ) consist complex disorder involve assembly cardiovascular risk factor related abdominal fat deposition insulin resistance . MS associate cardiovascular disease , increase overall mortality 1.5 time cardiovascular mortality 2.5 time . In 2001 , National Cholesterol Education Program - Panel National Cholesterol Education Program ( NCEP - ATP III ) , prepare another proposal . According NCEP ATP III , SM represent combination least three component .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Age 18 60 Both sex Renal transplant recipient Renal Transplant Unit , Hospital das Clinicas , FMUSP live donor decease Use immunosuppressive regimen consist tacrolimus , mycophenolate sodium prednisone Presence severe disease reduce life expectancy Presence diabetic nephropathy Presence cardiac arrhythmia affect blood pressure measurement Patients BMI ≥ 40 kg / m² Calculated creatinine clearance Cockroft Gault≤ 40ml/min Transplantation multiple organ organ transplant prior distinct kidney</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Renal transplantation</keyword>
</DOC>